Tamtam Try Tamtam free
Tate & Lyle logo

Tate & Lyle account plan

Healthy tastier food ingredients

At a glance

Tate & Lyle makes sweetening, mouthfeel and fortification ingredients for food and drink makers in 120 countries; FY2026 revenue was £2,006m.

Tate & Lyle is a speciality food and beverage ingredients business that turns crops such as corn, stevia and citrus peel into over 1,000 ingredients for sweetening, mouthfeel and fortification, mainly for beverage, dairy, soups, sauces and dressings, and bakery and snacks. After combining with CP Kelco in November 2024 it had 4,840 employees, 24 manufacturing sites in 11 countries and customers in 120 countries at 31 March 2026. In the year to 31 March 2026 statutory revenue was £2,006m, adjusted EBITDA £415m and statutory profit before tax £131m. It is a UK-listed PLC whose shareholders approved a recommended acquisition by Ingredion on 28 July 2026, with completion expected in the second half of calendar 2027.

Business units

Strategic priorities

Volume-led top-line growth
The stated number one priority is to deliver volume-led top-line growth, through customer segmentation into partner, enterprise, accelerator and core accounts, realigned customer-facing teams and solution selling; solutions reached 58% of new business wins by value in H1 FY2027.
CP Kelco combination benefits
The US$50m cost synergy run-rate was reached; revenue synergies of around US$70 million (10% of CP Kelco's revenue) are targeted by end FY2029, through cross-selling and moving CP Kelco customers from distributors to direct service.
Productivity programme
Savings of US$171m over three and a half years, with the target raised to US$200m by 31 March 2028 under the "Fuelling Growth" programme.
Balance sheet and cash conversion
Cash conversion above 75% each year, a progressive dividend and a long-term leverage target of 1x to 2.5x; leverage was 2.3x on a covenant basis at H1 FY2027.
Expansion in higher-growth markets and fibre
Growth in Asia, Middle East, Africa and Latin America, and in fibres such as PROMITOR Soluble fibre, with a target to provide 35 billion servings of 15 g of fibre by 2030.

Latest results

For the six months to 30 September 2026, revenue was £1,039m, up 1% in constant currency, with volume/mix +3% partly offset by a 2% price decline; excluding US tariff reimbursements and European bulk sweeteners, revenue grew 2%. Adjusted EBITDA fell 8% to £197m (margin 19.0%) on pricing, investment in capabilities and IT, and cost inflation, particularly in EMEA, and statutory profit before tax fell 37% to £46m. Free cash flow was £100m at 75% cash conversion and net debt £959m. The FY2027 outlook is maintained: modest revenue growth weighted to the second half and broadly flat EBITDA before the c.US$20 million bio-gums rescheduling impact, with cost inflation to be passed through in the 2027 framework agreements.

Investments and deals

Ingredion acquisition
Ingredion's recommended offer of up to 615 pence per share was approved by shareholders on 28 July 2026 with 98.64% of votes in favour; approvals are received in six jurisdictions, six remain, and completion is expected in the second half of calendar 2027.
CP Kelco integration
The combination completed on 15 November 2024 and the group has operated as one company since 1 April 2025; integration costs were £35m in FY2026 and £11m in H1 FY2027.
Bio-gums capacity consolidation
The expected c.US$20 million benefit moved from FY2027 to FY2028; the consolidation is progressing as planned.
Commercial technology
Around US$10 million in new technology and digital tools, including a generative AI tool for sales and technical teams, and a single common CRM platform implemented in August 2026.
Capital expenditure
FY2027 capex guidance is £110m to £130m; H1 FY2027 capex was £48m. A group-wide warehousing optimisation project is planned.

Challenges and risks

Cost inflation in Europe
The Middle East conflict has been more protracted than anticipated, with effects more pronounced in Europe; EMEA EBITDA fell 28% in H1 FY2027 and the company calls it a tougher cost environment than anticipated.
Soft consumer demand and pricing
Consumer demand softened after tariffs, affordability is an issue in Europe and the US, and strategic pricing actions cost 2% of revenue in H1 FY2027.
Declining bulk sweeteners
European bulk sweeteners and co-products accounted for around 40% of the EMEA FY2026 revenue decline on lower sugar pricing.
Competition from China
Excess China capacity has heightened competition elsewhere in Asia, in sweeteners and some gums.
Takeover uncertainty
Because the Ingredion deal may complete in the going concern period, the directors and auditor flag a material uncertainty related to going concern.

What leadership says

“The Group performed well in the first half with a return to top-line growth and profit in line with our expectations.”

Nick Hampton, Chief Executive · Results for the six months to 30 September 2026, 5 November 2026

“As we move into the 2027 financial year, we are determined to put that right.”

Nick Hampton, Chief Executive · FY2026 results presentation and Q&A, 21 May 2026

“crystal clear: deliver top-line growth and improve our financial performance”

David Hearn, Chair · Annual Report 2026, 2 June 2026

“the litmus test will be how we perform in the coming financial year and beyond”

Sarah Kuijlaars, Chief Financial Officer · Annual Report 2026, 2 June 2026

Where a supplier can help

Sales enablement and CRM
The new customer segmentation, single CRM platform, generative AI tool and Commercial Academy for solution selling create demand for sales analytics, content and training tools.
Energy and procurement savings
Cost inflation in European energy and the US$200m productivity target open doors for energy management, procurement and process-efficiency suppliers.
Plant operations and fermentation scale-up
The bio-gums consolidation, Six Sigma productivity projects at plants like Lafayette and a plant equipment failure in H1 FY2027 point to needs in process engineering, maintenance and reliability.
Warehousing and supply chain
The planned group-wide warehousing optimisation and inventory built to manage tariffs suggest openings for logistics and supply-chain planning partners.
Integration and post-merger services
The pending Ingredion acquisition and the CP Kelco integration involve systems, data and organisational work where advisers and integrators can help.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Tate & Lyle?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Tate & Lyle

What does Tate & Lyle do?

Tate & Lyle makes speciality food and beverage ingredients for sweetening, mouthfeel and fortification, such as stevia, sucralose, pectins, gums, starches and fibres. Food and drink makers use them to cut sugar, calories and fat or add fibre.

What is Tate & Lyle's revenue?

Statutory revenue was £2,006m in the year to 31 March 2026, and £1,039m in the six months to 30 September 2026.

How many employees does Tate & Lyle have?

It had 4,840 employees at 31 March 2026, with sites in 38 countries.

Who leads Tate & Lyle?

Nick Hampton is Chief Executive, Sarah Kuijlaars Chief Financial Officer and David Hearn Chair.

Is Tate & Lyle being acquired?

Yes. Shareholders approved Ingredion's recommended offer on 28 July 2026, and completion is expected in the second half of calendar 2027, subject to regulatory approvals.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)